NAMS
NewAmsterdam Pharma·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
4.39 / 10Overall Score
NeturalInvestment Rating
4.39 / 10Overall Score
NeturalInvestment Rating
Should I Buy NAMS Now?
- Based on a composite score of 4.39/10, we rate NAMS as a Netural. Our analysis breaks down into 2.49/10 for Fundamentals, 3.72/10 for Technicals, and 5.67/10 for Sentiment, indicating the stock is likely to consolidate sideways.
What is the current technical signals for NAMS?
Is NAMS fundamentally strong?
What is the market sentiment for NAMS?
Should I Buy NAMS Now?
- Based on a composite score of 4.39/10, we rate NAMS as a Netural. Our analysis breaks down into 2.49/10 for Fundamentals, 3.72/10 for Technicals, and 5.67/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is NAMS fundamentally strong?
What is the current technical signals for NAMS?
What is the market sentiment for NAMS?
